Animal Testing Alternatives
"Animal Testing Alternatives" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.
| Descriptor ID |
D000826
|
| MeSH Number(s) |
E05.017.080.100
|
| Concept/Terms |
Animal Testing Alternatives- Animal Testing Alternatives
- Alternative, Animal Testing
- Alternatives, Animal Testing
- Animal Testing Alternative
- Testing Alternative, Animal
- Testing Alternatives, Animal
- Alternatives to Animal Testing
|
Below are MeSH descriptors whose meaning is more general than "Animal Testing Alternatives".
Below are MeSH descriptors whose meaning is more specific than "Animal Testing Alternatives".
This graph shows the total number of publications written about "Animal Testing Alternatives" by people in this website by year, and whether "Animal Testing Alternatives" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Animal Testing Alternatives" by people in Profiles.
-
[Current challenges and future perspectives of pharmacological testing using new approach methodologies]. Nihon Yakurigaku Zasshi. 2021; 156(4):208-213.
-
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines. Arch Toxicol. 2020 06; 94(6):2263-2272.
-
R2N and the use of alternative methods in COVID-19 research. ALTEX. 2020; 37(4):683-684.
-
Towards animal free and science based measures of critical quality attributes for vaccine quality control and release. Vaccine. 2019 06 27; 37(29):3745-3746.
-
The US Federal Tox21 Program: A strategic and operational plan for continued leadership. ALTEX. 2018; 35(2):163-168.
-
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. Toxicol Appl Pharmacol. 2018 09 01; 354:3-6.
-
Development of in vitro tests for detection of extraneous agents. Dev Biol Stand. 1986; 64:195-8.